Morena is the Senior Scientist of Immunology Lab at Nouscom, a biotech dedicated to the development of next generation cancer immunotherapies. Her focus is Preclinical Immunology for Vaccine and Immunotherapy.
Prior to Nouscom, Morena was a Scientist at Okairos, a company developing genetic vaccines for infectious diseases. She worked on many aspects of Vaccine programs and Immunology, including the validation of Adenovectors vaccine platform in pre-clinical models, mechanism of immunization, adjuvants, design of improved vaccines.
Morena received her PhD in Molecular Biotechnology from University of Perugia. She conducted post-doctoral studies in Immunology at Harvard Medical School, focusing on mechanism of immunoregulation and autoimmunity.